You are now viewing 1 - 10 of 170 results
January 1, 2009 | Journal Article
This study explores the feasibility and desirability of proposals to change university patenting and licensing practices to promote access to medicines in the developing world.
March 1, 2009 | Issue Brief
Despite the introduction of a Medicare outpatient prescription drug benefit in January 2006, roughly the same proportion of elderly Medicare beneficiaries in 2003 and 2007--about 8 percent--skipped filling at least one prescription drug because of cost concerns, according to a new national study by the Center for Studying Health System Change.
July 11, 2009 | Program Result
Addressing Tobacco in Managed Care supported evaluations of replicable efforts by managed care organizations to integrate effective tobacco-cessation interventions into everyday clinical practice and the basic health care these organizations provide.
November 12, 2009 | Journal Article
Direct-to-consumer advertising (DTCA) of prescription drugs has remained controversial since regulations were liberalized by the FDA in 1997. This study reviewed empirical evidence addressing the claims made in the policy debate for and against DTCA.
May 11, 2011 | Story
To join the conversation about the conference, follow the Twitter hashtag #G4H11 and visit the Pioneering Ideas blog during the week of May 16 for event news and highlights.
March 31, 2011 | Program Result
Progress and lessons learned from two programs that seek to advance the impact digital games can have on health.
March 25, 2013 | Program Result
Developing and promoting a rapid-learning health system, in which health information in large databases is analyzed to improve health care - the work of Lynn Etheredge and the Health Insurance Reform Project at George Washington University.
October 28, 2012 | Journal Article
The Pioneer Portfolio is the Robert Wood Johnson Foundation’s innovation arm, committed to harnessing a pipeline of ideas to serve the social good.
March 1, 2011 | Journal Article
Kids with pneumonia treated after an office visit are more likely to receive broad-spectrum antibiotics despite evidence of little benefit over narrow-spectrum penicillins.
September 1, 2011 | Journal Article
Using market exclusivity to promote pharmaceutical innovation can lead to positive outcomes, but the practice is also characterized by waste and collateral effects.